Stock 301130 JILIN PROVINCE XIDIAN PHARMACEUTICAL SCI-TECH DEVELOPMENT CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

All News Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd

Equities

301130

CNE1000058C4

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-07-14 pm EDT 		5-day change 1st Jan Change
23.11 CNY -3.31% Intraday chart for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd -0.22% -17.11%
Jul. 01 Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024. CI
Jun. 04 Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 12 June 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024.
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 12 June 2024
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Cash Dividend for 2023
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024.
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on February 23, 2024.
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Executive Appointments
CI
Xidian Pharmaceutical’s Depression Drug Added to Procurement Program
MT
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Cash Dividend for 2022, Payable on June 12, 2023
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Proposes Final Cash Dividend for the Year 2022
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Certain A Shares of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 24-FEB-2023.
CI
Xidian Pharma's Shareholder and Party Acting in Concert Plan to Unload Stake
CI
Certain A Shares of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 24-JAN-2023.
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 301130 Stock
  4. News Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd